NIH-funded research R21 grant

Understanding how certain fatty acids cause a specific type of cell death

Official title: Elucidate the mechanisms of ferroptosis mediated by nonconjugated and conjugated polyunsaturated fatty acids

Funded at University of Washington · NIH-11036168 · Data updated 2026-11-12

This study is looking at a special way that cancer cells can die, called ferroptosis, and how certain healthy fats in our diet might help make this happen, with the hope of finding new treatments for cancer that could benefit patients.

Quick facts

Grant typeR21 grant
Study typeNIH-funded research
Funding institutionUniversity of Washington
NIH-funded
Lab location1 site (Seattle, United States)
Project startSeptember 13, 2024
Project endAugust 31, 2026
Funding year2024
Award (this year)$414,979
NIH project number1R21AT013103-01
Project IDNIH-11036168 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates for this research are patients with cancers that may be sensitive to ferroptosis.

Less likely to help

Patients with non-cancerous conditions or those whose cancers are resistant to ferroptosis may not benefit from this research.

What this research studies

This research investigates ferroptosis, a unique form of cell death influenced by iron and fatty acids. It focuses on how different types of polyunsaturated fatty acids (PUFAs), particularly those with conjugated double bonds, can enhance this process in cancer cells. By examining the mechanisms behind this cell death, the research aims to identify potential therapeutic strategies that could leverage ferroptosis to treat cancer. Patients may benefit from insights that could lead to new cancer treatments based on dietary components.

Why it matters

Potential benefit: If successful, this research could lead to innovative cancer therapies that utilize dietary fatty acids to induce cancer cell death.

How similar studies have gone: While the specific approach of using conjugated fatty acids to induce ferroptosis is relatively novel, there is growing evidence supporting the role of ferroptosis in cancer treatment.

Where this research is happening

  • University of Washington
    Seattle, United States
    Active

Researchers

  • Principal investigator: Xu, Libin — University of Washington
  • Study coordinator: Xu, Libin

Related research

Other NIH-funded projects on the same topics.

  • Making genetic testing more accessible to the public

    This study is all about making it easier for people at risk of certain cancers, like breast, ovarian, and colon cancers, to get genetic testing, so we can find out what helps them access these important services and understand how they can benefit from them.

    NIH research University of Washington · Seattle, United States · NIH-9845571

  • Breast cancer diagnosis in low-resource settings using millifluidics and fast digital imaging in Ghana

    A new project will test a fast, low-cost way to diagnose breast cancer at the point of care in Ghana using small-batch fluidics and direct digital imaging.

    NIH research University of Washington · Seattle, United States · NIH-11645064

  • Binaural Hearing and Speech in Noise in Children

    This project explores how children hear speech in noisy classrooms using how the two ears work together to see if binaural processing differences explain why some kids struggle more than others.

    NIH research University of Washington · Seattle, United States · NIH-11631484

  • Neural circuits that control pain aversion in the brain

    Researchers are exploring how a specific brain area helps people feel and avoid pain, with potential to lead to better pain treatments.

    NIH research University of Washington · Seattle, United States · NIH-11629742

  • United World Antiviral Research Network (UWARN)

    A collaborative, international effort is testing new virus surveillance and evolution ideas to help people living with HIV and communities in LMICs stay safer from current and emerging viruses.

    NIH research University of Washington · Seattle, United States · NIH-11627864

  • HF endotypes in heart failure using ethical multi-modal AI and molecular data

    A patient-friendly project that uses advanced AI and multiple kinds of health data to identify distinct heart failure subtypes that could guide personalized care.

    NIH research University of Washington · Seattle, United States · NIH-11621806

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.